Ying-Jan Wang

27PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsMedical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 27, 2026
Stromal CCL2/CXCL10/SPARC axes drive pro-tumor CHI3L1 expression for microenvironmental modulation in pancreatic cancer progression and therapeutic innovation.

|Jan 14, 2026
Rab37-mediated OPN secretion enriches SPP1+ macrophages through autocrine-paracrine signaling to drive lung tumor progression.

You-En Yang, Yu-An Lin, Lun-Ling Ling

|Jan 04, 2026
Post-translational modifications of immune checkpoints: molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications.

Hung-Chia Hsieh, Lun-Ling Ling, Yi-Ching Wang

|May 29, 2025
Macrophage activation determines muscle wasting in pancreatic cancer.

Chia-Jung Chang, Po-Hsien Huang, Szu-Ying Chen

|Apr 16, 2025
Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response.

Hung-Chia Hsieh, Ming-Jer Young, Kuan-Yu Chen

|Feb 21, 2025
GDP-bound Rab37 modulates M2-like tumor-associated macrophage polarization by attenuating STAT1 translocation to downregulate the type I IFN pathway.

Chen-Tai Hong, You-En Yang, Hsueh-Fen Juan

Pageof 5

Frequent Collaborators

3 joint publications

Ming-Jer Young

3 joint publications

Jan-Jong Hung

3 joint publications

Wu-Chou Su

2 joint publications

Lun-Ling Ling